Huisman, H.

patient biopsy study cancer grade imaging mr-gb prostate gleason trusbx bibw 2992 tumour cycle inhibitor kinase performance cohort undergrading tyrosine diarrhoea treatment 14 days value receptor factor tumours 70 mg prostate cancer phase prostatectomy aggressiveness performance rates epidermal 10- core trusbx grade 3 diarrhoea range toxicity resonance gleason grades 10- pharmacokinetic urology table level dose levels pretreatment european region growth antigen therapy diffusion resonance imaging diffusion coef ficient radboud university nijmegen volume diffusion-weighted imaging score difference plasma assessment analysis parameter administration concentration hambrock transrectal pretreatment assessment diffusion-weighted result gleason grade needle prostate-speci fic antigen sample prostate needle biopsy –guided pathology nijmegen schedule 2-weighted